1 Introduction to Research & Analysis Reports 1.1 Cysticercosis Treatment Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Cysticercosis Treatment Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Cysticercosis Treatment Overall Market Size 2.1 China Cysticercosis Treatment Market Size: 2021 VS 2027 2.2 China Cysticercosis Treatment Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Cysticercosis Treatment Players in China Market 3.2 Top China Cysticercosis Treatment Companies Ranked by Revenue 3.3 China Cysticercosis Treatment Revenue by Companies 3.4 Top 3 and Top 5 Cysticercosis Treatment Companies in China Market, by Revenue in 2020 3.5 Companies Cysticercosis Treatment Product Type 3.6 Tier 1, Tier 2 and Tier 3 Cysticercosis Treatment Players in China Market 3.6.1 List of Tier 1 Cysticercosis Treatment Companies in China 3.6.2 List of Tier 2 and Tier 3 Cysticercosis Treatment Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Cysticercosis Treatment Market Size Markets, 2021 & 2027 4.1.2 Praziquantel 4.1.3 Albendazole 4.2 By Type - China Cysticercosis Treatment Revenue & Forecasts 4.2.1 By Type - China Cysticercosis Treatment Revenue, 2016-2021 4.2.2 By Type - China Cysticercosis Treatment Revenue, 2022-2027 4.2.3 By Type - China Cysticercosis Treatment Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Cysticercosis Treatment Market Size, 2021 & 2027 5.1.2 Adult 5.1.3 Elderly 5.2 By Application - China Cysticercosis Treatment Revenue & Forecasts 5.2.1 By Application - China Cysticercosis Treatment Revenue, 2016-2021 5.2.2 By Application - China Cysticercosis Treatment Revenue, 2022-2027 5.2.3 By Application - China Cysticercosis Treatment Revenue Market Share, 2016-2027 6 Cysticercosis Treatment Companies Profiles 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Company Details 6.1.2 GlaxoSmithKline Business Overview 6.1.3 GlaxoSmithKline Cysticercosis Treatment Introduction 6.1.4 GlaxoSmithKline Cysticercosis Treatment Revenue in China Market (2016-2021) 6.1.5 GlaxoSmithKline Recent Developments 6.2 Amedra Pharmaceuticals 6.2.1 Amedra Pharmaceuticals Company Details 6.2.2 Amedra Pharmaceuticals Business Overview 6.2.3 Amedra Pharmaceuticals Cysticercosis Treatment Introduction 6.2.4 Amedra Pharmaceuticals Cysticercosis Treatment Revenue in China Market (2016-2021) 6.2.5 Amedra Pharmaceuticals Recent Developments 6.3 Bayer 6.3.1 Bayer Company Details 6.3.2 Bayer Business Overview 6.3.3 Bayer Cysticercosis Treatment Introduction 6.3.4 Bayer Cysticercosis Treatment Revenue in China Market (2016-2021) 6.3.5 Bayer Recent Developments 6.4 Klarsehen India 6.4.1 Klarsehen India Company Details 6.4.2 Klarsehen India Business Overview 6.4.3 Klarsehen India Cysticercosis Treatment Introduction 6.4.4 Klarsehen India Cysticercosis Treatment Revenue in China Market (2016-2021) 6.4.5 Klarsehen India Recent Developments 6.5 Ranbaxy 6.5.1 Ranbaxy Company Details 6.5.2 Ranbaxy Business Overview 6.5.3 Ranbaxy Cysticercosis Treatment Introduction 6.5.4 Ranbaxy Cysticercosis Treatment Revenue in China Market (2016-2021) 6.5.5 Ranbaxy Recent Developments 6.6 Salius 6.6.1 Salius Company Details 6.6.2 Salius Business Overview 6.6.3 Salius Cysticercosis Treatment Introduction 6.6.4 Salius Cysticercosis Treatment Revenue in China Market (2016-2021) 6.6.5 Salius Recent Developments 6.7 Cipla 6.7.1 Cipla Company Details 6.7.2 Cipla Business Overview 6.7.3 Cipla Cysticercosis Treatment Introduction 6.7.4 Cipla Cysticercosis Treatment Revenue in China Market (2016-2021) 6.7.5 Cipla Recent Developments 6.8 Pharmaco-Kinesis 6.8.1 Pharmaco-Kinesis Company Details 6.8.2 Pharmaco-Kinesis Business Overview 6.8.3 Pharmaco-Kinesis Cysticercosis Treatment Introduction 6.8.4 Pharmaco-Kinesis Cysticercosis Treatment Revenue in China Market (2016-2021) 6.8.5 Pharmaco-Kinesis Recent Developments 6.9 Bonaide 6.9.1 Bonaide Company Details 6.9.2 Bonaide Business Overview 6.9.3 Bonaide Cysticercosis Treatment Introduction 6.9.4 Bonaide Cysticercosis Treatment Revenue in China Market (2016-2021) 6.9.5 Bonaide Recent Developments 6.10 Taj Pharmaceuticals 6.10.1 Taj Pharmaceuticals Company Details 6.10.2 Taj Pharmaceuticals Business Overview 6.10.3 Taj Pharmaceuticals Cysticercosis Treatment Introduction 6.10.4 Taj Pharmaceuticals Cysticercosis Treatment Revenue in China Market (2016-2021) 6.10.5 Taj Pharmaceuticals Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Cysticercosis Treatment Market Opportunities & Trends in China Market Table 2. Cysticercosis Treatment Market Drivers in China Market Table 3. Cysticercosis Treatment Market Restraints in China Market Table 4. Key Players of Cysticercosis Treatment in China Market Table 5. Top Cysticercosis Treatment Players in China Market, Ranking by Revenue (2019) Table 6. China Cysticercosis Treatment Revenue by Companies, (US$, Mn), 2016-2021 Table 7. China Cysticercosis Treatment Revenue Share by Companies, 2016-2021 Table 8. Companies Cysticercosis Treatment Product Type Table 9. List of Tier 1 Cysticercosis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Cysticercosis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – China Cysticercosis Treatment Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - China Cysticercosis Treatment Revenue (US$, Mn), 2016-2021 Table 13. By Type - China Cysticercosis Treatment Revenue (US$, Mn), 2022-2027 Table 14. By Application – China Cysticercosis Treatment Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - China Cysticercosis Treatment Revenue (US$, Mn), 2016-2021 Table 16. By Application - China Cysticercosis Treatment Revenue (US$, Mn), 2022-2027 Table 17. GlaxoSmithKline Company Details Table 18. GlaxoSmithKline Business Overview Table 19. GlaxoSmithKline Cysticercosis Treatment Product Table 20. GlaxoSmithKline Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 21. GlaxoSmithKline Recent Developments Table 22. Amedra Pharmaceuticals Company Details Table 23. Amedra Pharmaceuticals Business Overview Table 24. Amedra Pharmaceuticals Cysticercosis Treatment Product Table 25. Amedra Pharmaceuticals Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 26. Amedra Pharmaceuticals Recent Developments Table 27. Bayer Company Details Table 28. Bayer Business Overview Table 29. Bayer Cysticercosis Treatment Product Table 30. Bayer Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 31. Bayer Recent Developments Table 32. Klarsehen India Company Details Table 33. Klarsehen India Business Overview Table 34. Klarsehen India Cysticercosis Treatment Product Table 35. Klarsehen India Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 36. Klarsehen India Recent Developments Table 37. Ranbaxy Company Details Table 38. Ranbaxy Business Overview Table 39. Ranbaxy Cysticercosis Treatment Product Table 40. Ranbaxy Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 41. Ranbaxy Recent Developments Table 42. Salius Company Details Table 43. Salius Business Overview Table 44. Salius Cysticercosis Treatment Product Table 45. Salius Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 46. Salius Recent Developments Table 47. Cipla Company Details Table 48. Cipla Business Overview Table 49. Cipla Cysticercosis Treatment Product Table 50. Cipla Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 51. Cipla Recent Developments Table 52. Pharmaco-Kinesis Company Details Table 53. Pharmaco-Kinesis Business Overview Table 54. Pharmaco-Kinesis Cysticercosis Treatment Product Table 55. Pharmaco-Kinesis Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 56. Pharmaco-Kinesis Recent Developments Table 57. Bonaide Company Details Table 58. Bonaide Business Overview Table 59. Bonaide Cysticercosis Treatment Product Table 60. Bonaide Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 61. Bonaide Recent Developments Table 62. Taj Pharmaceuticals Company Details Table 63. Taj Pharmaceuticals Business Overview Table 64. Taj Pharmaceuticals Cysticercosis Treatment Product Table 65. Taj Pharmaceuticals Cysticercosis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 66. Taj Pharmaceuticals Recent Developments List of Figures Figure 1. Cysticercosis Treatment Segment by Type Figure 2. Cysticercosis Treatment Segment by Application Figure 3. China Cysticercosis Treatment Market Overview: 2020 Figure 4. China Cysticercosis Treatment Market Size: 2021 VS 2027 (US$, Mn) Figure 5. China Cysticercosis Treatment Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Cysticercosis Treatment Revenue in 2020 Figure 7. By Type - China Cysticercosis Treatment Revenue Market Share, 2016-2027 Figure 8. By Application - China Cysticercosis Treatment Revenue Market Share, 2016-2027 Figure 9. GlaxoSmithKline Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Amedra Pharmaceuticals Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Bayer Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Klarsehen India Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Ranbaxy Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Salius Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Cipla Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Pharmaco-Kinesis Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. Bonaide Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. Taj Pharmaceuticals Cysticercosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

GlaxoSmithKline Amedra Pharmaceuticals Bayer Klarsehen India Ranbaxy Salius Cipla Pharmaco-Kinesis Bonaide Taj Pharmaceuticals